Showing results (391-400 of 7,832) with videos related to
Sort By:
Pageof 784
Archives of General Psychiatry|May 1, 1987
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response studyT Sunderland, P N Tariot, R M Cohen, et al.Brain Research Bulletin|December 26, 2001
Genetic perspectives on the serotonin transporterD L Murphy, Q Li, S Engel, et al.Pharmacology, Biochemistry, and Behavior|May 1, 1991
Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in ratsC S Aulakh, J Zohar, K M Wozniak, et al.Journal of Abnormal Psychology|July 15, 2000
Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approachN B Schmidt, J Storey, B D Greenberg, et al.Biological Psychiatry|April 1, 1993
Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controlsJ R Joseph-Vanderpool, F M Jacobsen, D L Murphy, et al.European Journal of Pharmacology|May 7, 1982
Cardiovascular changes in response to selective monoamine oxidase inhibition in the ratR M Cohen, I C Campbell, I Yamaguchi, et al.Archives of General Psychiatry|August 1, 1986
Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of dosesP N Tariot, T Sunderland, H Weingartner, et al.Journal of Clinical Psychopharmacology|February 1, 1992
A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorderT A Pigott, F L'Heureux, J L Hill, et al.Clinical Pharmacology and Therapeutics|February 1, 1977
Reduction in plasma norepinephrine during fenfluramine treatmentC E de la Vega, S Slater, M G Ziegler, et al.Pharmacology, Biochemistry, and Behavior|January 1, 1989
Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in ratsC S Aulakh, M Haass, J Zohar, et al.Pageof 784